Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$3.91 - $6.73 $255,463 - $439,711
-65,336 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$6.54 - $15.31 $427,297 - $1 Million
65,336 New
65,336 $442,000

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $102M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Rex Capital Advisors, LLC Portfolio

Follow Rex Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rex Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rex Capital Advisors, LLC with notifications on news.